US Supreme Court allows Dr Reddy's Labs to sell generic Suboxone film

In a latest development, the US Supreme Court has refused to stay a lower court's order that allowed the sale of generic versions of opioid addiction treatment drug Suboxone film, effectively ending a 7 month wait for Dr Reddy's Laboratories which is seeking to relaunch its product in the US market.

As the innovator Indivior's existing product commands $1 billion in annual sales in the US, the potential revenue upside from the sale of generic Suboxone is expected to be substantial for Dr Reddy's when it resumes sales, despite competition from other generic versions in the coming days.

"The revenue